Ovulation Induction in the Ovulatory Woman
review
OA: closed
CC0
⤵ 3 in-corpus citations
⚙
AI-generated summary
by claude@2026-06, 2026-06-09
ⓘ
Controlled ovarian hyperstimulation with clomiphene citrate or gonadotropins combined with intrauterine insemination may improve pregnancy rates compared to expectant management for subfertile women.
⚙
AI-generated deep summary
by claude@2026-06, 2026-06-11
· read from full text
ⓘ
I can’t access the paper content because the provided text is blocked by an Anubis proof-of-work page rather than the article itself, so there’s no information about study design, population, methods, results, or limitations to summarize. The only available content describes a website’s anti-scraping mechanism and does not contain biomedical findings. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Abstract
Controlled ovarian hyperstimulation is frequently employed as empiric therapy for the treatment of unexplained infertility, mild male factor, cervical factor, and treated endometriosis. Prescribed in the form of either clomiphene citrate or gonadotropins, it is often combined with intrauterine insemination and offered to patients as a less expensive and less invasive alternative to the assisted reproductive technologies. Efficacy studies for these regimens are very important, as patients who would appear to be ideal candidates for this empiric therapy frequently do not suffer from absolute infertility; rather they are often subfertile, and may conceive spontaneously given enough time. Although there are few well-designed, controlled trials that assess the effectiveness of this form of therapy, the majority of the published data do suggest an improvement in pregnancy rates when compared to expectant management.
Full text
1,068 characters
· extracted from
oa-doi-fallback
· click to expand
Making sure you're not a bot!
Loading...
You are seeing this because the administrator of this website has set up Anubis to protect the server against the scourge of AI companies aggressively scraping websites. This can and does cause downtime for the websites, which makes their resources inaccessible for everyone.
Anubis is a compromise. Anubis uses a Proof-of-Work scheme in the vein of Hashcash, a proposed proof-of-work scheme for reducing email spam. The idea is that at individual scales the additional load is ignorable, but at mass scraper levels it adds up and makes scraping much more expensive.
Ultimately, this is a placeholder solution so that more time can be spent on fingerprinting and identifying headless browsers (EG: via how they do font rendering) so that the challenge proof of work page doesn't need to be presented to users that are much more likely to be legitimate.
Please note that Anubis requires the use of modern JavaScript features that plugins like JShelter will disable. Please disable JShelter or other such plugins for this domain.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.
My notes (saved in your browser only)
⚙
Ask this paper
AI returns verbatim quotes from the full text
· source: oa-doi-fallback
ⓘ
Condition tags
endometriosisinfertility
MeSH descriptors
Infertility, Female
Ovulation
Ovulation Induction
Clomiphene
Clomiphene
Endometriosis
Endometriosis
Female
Fertility Agents, Female
Fertility Agents, Female
Gonadotropin-Releasing Hormone
Gonadotropin-Releasing Hormone
Gonadotropins, Pituitary
Gonadotropins, Pituitary
Humans
Infertility, Female
Infertility, Female
Infertility, Female
Infertility, Male
Infertility, Male
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart;
here are the lists.
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-08-04T06:16:37.499272+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:10:57.821266+00:00
License: CC0
· commercial use OK